MediWound Ltd. (MDWD)
NASDAQ: MDWD · Real-Time Price · USD
12.03
-0.19 (-1.55%)
Oct 14, 2026, 12:38 PM EDT - Market open
MediWound Market Cap
MediWound has a market cap or net worth of $155.31 million as of October 14, 2026. It is the 22,368th most valuable company in the world and the 3,779th biggest in the United States. Its market cap has decreased by 21.64% in one year.
Market Cap
155.31M
Enterprise Value
128.57M
1-Year Change
-21.64%
Global Rank
Country Rank
#3,779 United States
Category
ChartMarket Cap Chart
Since March 20, 2014, MediWound's market cap has decreased from $352.30M to $155.31M, a decrease of -55.92%. That is a compound annual growth rate of -6.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2026 | 155.31M | -34.39% |
| Dec 31, 2025 | 236.70M | 26.51% |
| Dec 31, 2024 | 187.10M | 99.47% |
| Dec 29, 2023 | 93.80M | 19.49% |
| Dec 30, 2022 | 78.50M | 22.08% |
| Dec 31, 2021 | 64.30M | -36.15% |
| Dec 31, 2020 | 100.70M | 19.45% |
| Dec 31, 2019 | 84.30M | -23.22% |
| Dec 31, 2018 | 109.80M | -8.58% |
| Dec 29, 2017 | 120.10M | 19.98% |
| Dec 30, 2016 | 100.10M | -45.60% |
| Dec 31, 2015 | 184.00M | 35.39% |
| Dec 31, 2014 | 135.90M | -61.42% |
| Mar 20, 2014 | 352.30M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Compass Therapeutics | 168.00M |
| Canton Strategic Holdings | 166.14M |
| ALX Oncology Holdings | 165.93M |
| Protara Therapeutics | 163.69M |
| AN2 Therapeutics | 163.02M |
| Veraxa Biotech AG | 162.63M |
| Coherus Oncology | 159.91M |
| Nkarta | 157.57M |